BTIG is out in defense of NxStage Medical, Inc. (NXTM) following the company's Q4, FY16 results reported on Wednesday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Piper Jaffray Cuts Price Target on Nxstage Medical (NXTM) Following Mixed 4Q Results February 11, 2016 9:23 AM Form 10-K NxStage Medical, Inc. For: Dec 31February 11, 2016 8:29 AM Form SC 13G/A NxStage Medical, Inc. Filed by: VANGUARD GROUP INCFebruary 11, 2016 7:45 AM Form 4 NxStage Medical, Inc. For: Feb 09 Filed by: Turk Joseph E JrFebruary 10, 2016 4:57 PM Form 8-K NxStage Medical, Inc. For: Feb 10February 10, 2016 8:19 AM